Skip to main content
Equibles

PROTEAN · Protean eGov Technologies Limited

Use PROTEAN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PROTEAN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
713.35 INR -10.30 (-1.42%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 31.34K Avg daily vol (3M) 78.4K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close713.35 INR Open732.55 INR Day707.90–737.45 INR 52W close446.70–849.60 INR Avg vol 30d54K Last earningsNov 5, 2026 DataNov 2023–Nov 2026

Latest documents

2026
Nov 5
Earnings call
Q2 revenue rises as major mandates near completion

Protean eGov Technologies reported Q2FY27 revenue of INR 271 crores, up 8% year-on-year, and normalized EBITDA of INR 53 crores, up 22% year-on-year; two major RFP mandates neared implementation completion and H1FY27 new initiatives grew 56%.

Read from the first part of this long document
4 source passages
Protean delivered a steady and resilient performance in Q2FY27. Revenue from operations grew 8% year-on-year to INR 271 crores Excluding these investments, the EBITDA would have been INR 53 crores, which was an increase of 22% year-on-year The two large RFP mandates where we invested a lot of our bandwidth and capital over the year, the CERSAI CKYCRR 2.0 and the UIDAI Aadhaar Seva Kendra project, both are now nearing implementation completion. Our New Initiatives, in line with our strategy, contributed 16% of total revenue in H1FY27, compared to 12% in H1FY26, growing 56% year-on-year. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
· 2.22B INR 204.00M INR '25 Q4 · 2.11B INR 238.50M INR '26 Q1 · 2.50B INR 238.60M INR '26 Q2 · 2.29B INR 225.00M INR '26 Q3 ▲38.4% 3.08B INR 303.80M INR '26 Q4 ▲19% 2.51B INR 58.60M INR '27 Q1 LATEST ▲8.1% 2.71B INR 164.00M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 446.70 INR Now 713.35 INR · 66% Range high 849.60 INR
vs 200-day avg +22% vs 50-day avg +17%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:PROTEAN +7.6% +11.0% +10.8% +13.3% -5.6%

Exchange listing

Market
XBOM
Ticker
PROTEAN
ISIN
INE004A01022
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.proteantech.in/
Investor relations
https://www.proteantech.in/corporate-governance/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-08-28 10.00 INR
2025-08-29 10.00 INR
2024-09-06 10.00 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-05 Transcript
    Earnings Call
  • Earnings call · Q1 2027 2026-08-04 Audio Transcript
    Earnings Call
  • Earnings call · Q4 2026 2026-05-21 Audio Transcript
    Earnings Call for the Quarter Ended March 31, 2026